2010.09-2014.07            吉林大学          生命科学学院                  生物药学学士

2014.09-2019.07            清华大学          药学院                            生物学博士

2019.07-今                     清华大学          药学院                            博士后

研究方向：针对KRAS突变胰腺导管癌的药物递送

个人邮箱：liuhuiqin@mail.tsinghua.edu.cn

发表的学术论文

1. Liu Huiqin, Sun Mengnan, Liu Zhengsheng, Kong Chao, Kong Weijian, Ye Junxiao, Gong Jianan, Huang David.C.S., and Qian Feng. (2019). KRAS-enhanced macropinocytosis and reduced FcRn-mediated recycling sensitize pancreatic cancer to albumin-conjugated drugs. Journal of Controlled Release 296, 40–53. 

2. Wang Shujing, Liu Huiqin, Zhang Xinyi, and Qian Feng. (2015).  Intranasal and oral vaccination with protein-based antigens: Advantages, challenges and formulation strategies. Protein & Cell 6, 480–503.

3. Chao Kong, Yang Li, Zhengsheng Liu, Junxiao Ye, Zhaohui Wang, Ling Zhang, Weijian Kong, Huiqin Liu, Chun Liu, Huanhuan Pang, Zeping Hu, Jinming Gao, and Feng Qian.(2019). Targeting KRAS-mutant Pancreatic Cancer by Synergistic Blocking of Lysosomal Acidification and Rapid Drug Release. ACS Nano.